| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 06/01/2006 | US20060116390 Hepatitis c virus inhibitors |
| 06/01/2006 | US20060116385 Novel compounds having selective inhibiting effect at gsk3 |
| 06/01/2006 | US20060116384 1-Aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
| 06/01/2006 | US20060116326 Benzothiophene compounds having antiinfective activity |
| 06/01/2006 | US20060114552 Fluorinated crosslinked electro-optic materials and electro-optic devices therefrom |
| 06/01/2006 | CA2588713A1 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors |
| 06/01/2006 | CA2587888A1 Novel 4-aminopiperidine derivatives as plasmepsin ii inhibitors |
| 06/01/2006 | CA2587853A1 Gonadotropin releasing hormone receptor antagonists |
| 06/01/2006 | CA2586972A1 Cycloalkyl piperidine tachykinin receptor antagonists |
| 05/31/2006 | EP1661569A1 Compounds effecting glucokinase |
| 05/31/2006 | EP1661568A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661567A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661564A1 Heterocyclic compounds and their pharmaceutical use |
| 05/31/2006 | EP1661563A1 Compound effecting Glucokinase |
| 05/31/2006 | EP1660474A1 Substituted thiophenes and uses thereof |
| 05/31/2006 | EP1660461A1 Novel condensed n-pyrazinyl-sulphonamides and their use in the treatment of chemokine mediated diseases |
| 05/31/2006 | EP1660454A1 Azacyclic compounds as inhibitors of sensory neurone specific channels |
| 05/31/2006 | EP1660452A1 Quinoline derivatives as neutrophil elastase inhibitors and their use |
| 05/31/2006 | EP1660450A1 Monomers, oligomers and polymers of 2-functionalized and 2,7-difunctionalized carbazoles |
| 05/31/2006 | EP1660447A1 Cyclic amine base-1 inhibitors having a heterocyclic substituent |
| 05/31/2006 | EP1660427A1 Substituted arylalkanoic acid derivative and use thereof |
| 05/31/2006 | EP1660087A2 Quinolinone derivatives as inhibitors of c-fms kinase |
| 05/31/2006 | EP1660077A1 Indol-6 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 05/31/2006 | EP1556356B1 Tetrahydroquinoline derivatives as crth2 antagonists |
| 05/31/2006 | EP1420644B1 Substituted propargylamines |
| 05/31/2006 | EP1413305B1 Aryl (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence |
| 05/31/2006 | EP1401821A4 Novel phenylalkyl diamine and amide analogs |
| 05/31/2006 | EP1368336B1 Thiophene substituted amine derivatives as glyt-1 inhibitors |
| 05/31/2006 | EP1345922B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1318997B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317449B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317444B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1296931B1 Polyamine analogues as cytotoxic agents |
| 05/31/2006 | EP1270570B1 Amide compounds and use thereof |
| 05/31/2006 | EP1163238B1 Chemokine recpetor binding heterocyclic compounds |
| 05/31/2006 | EP0946501B1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 05/31/2006 | CN1780823A Heteroaromatic pentacyclic compound and medicinal use thereof |
| 05/31/2006 | CN1780822A Use of derivatives of 2, 4-dihydro- 1,2,4 triazole-3-thione as inhibitors of the enzyme myeloperoxidase (MPO) |
| 05/31/2006 | CN1780621A Sulfonamide derivatives as gamma secretase inhibitors. |
| 05/31/2006 | CN1780617A Imidazolin-2-ylaminophenyl amides as IP antagonists. |
| 05/31/2006 | CN1778797A Production of N-(pyrrolo[2,3-d] pyrimidine-5-) acyl glusate derivative and intermediate |
| 05/31/2006 | CN1257891C Nitrogenous five-membered ring compounds |
| 05/31/2006 | CN1257886C Dehydroamino acids compounds |
| 05/30/2006 | US7053223 Inhibitors of farnesyl protein transferase |
| 05/30/2006 | US7053110 Dietetics; osteoporosis; muscular disorders |
| 05/30/2006 | US7053105 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
| 05/30/2006 | US7053094 Increasing contractile force in cardiac muscle fiber by administering a N-[(3-yloxy)-phenyl]-arylamide derivatives; modulating at the cardiac sarcomere (cardiac beta myosin) for congestive heart failure |
| 05/30/2006 | US7053089 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate (NMDA) |
| 05/30/2006 | US7053088 Vanilloid receptor ligands and their use in treatments |
| 05/30/2006 | US7053086 For cancer therapy |
| 05/30/2006 | US7053085 EP4 receptor agonist, compositions and methods thereof |
| 05/30/2006 | US7053078 Serine protease inhibitors |
| 05/30/2006 | US7053057 Caspase inhibitors and uses thereof |
| 05/30/2006 | US7052742 Five membered-ring compounds and utilization thereof in liquid crystal mixtures |
| 05/30/2006 | CA2398159C Sulphonylaminocarbonyltriazolinones having substitutents bonded via oxygen |
| 05/30/2006 | CA2321380C 6-azauracil derivatives as thyroid receptor ligands |
| 05/26/2006 | WO2006055187A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 05/26/2006 | WO2006054560A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both |
| 05/26/2006 | WO2006054426A1 Hydrophobic fluorescent probe of high-fluorescent quantum efficiency type, and method of detecting biopolymer and method of detecting interaction between biopolymers by using the same |
| 05/26/2006 | WO2006054162A1 Azabicyclic muscarinic receptor antagonists |
| 05/26/2006 | WO2006053748A1 Substituted [(phenylethanoyl)amino] benzamides and the use thereof in the treatment of inflammatory and cardio-vascular diseases |
| 05/26/2006 | WO2006053643A1 N-heterocyclyl phthalic acid diamides as insecticides |
| 05/26/2006 | CA2588768A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both |
| 05/26/2006 | CA2588766A1 Heterocycle substituted carboxylic acids |
| 05/26/2006 | CA2588513A1 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 05/26/2006 | CA2587533A1 Amide derivatives, their manufacture and use as pharmaceutical agents |
| 05/26/2006 | CA2587511A1 Substituted [(phenylethanoyl)amino] benzamides and the use thereof in the treatment of inflammatory and cardio-vascular diseases |
| 05/26/2006 | CA2587482A1 N-heterocyclyl phthalic acid diamides as insecticides |
| 05/26/2006 | CA2585172A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 05/25/2006 | US20060111431 Thiophene carboxanmides as inhibitors of the enzyme ikk-2 |
| 05/25/2006 | US20060111401 Taxanes having a C10 carbonate substituent |
| 05/25/2006 | US20060111364 Reversible inhibitors of cysteine proteases S, K, F, L and B; N-[2-(Benzylamino)pyrimidin-4-yl]-N-(cyanomethyl)-L-phenylalaninamide |
| 05/25/2006 | US20060111353 2-Cyclohexyl-1-(4-methanesulfonyl-phenyl)-cyclopropanecarboxylic acid 5-chloro-thiazol-2-yl)-amide; antidiabetic agents; non-insulin dependent diabetes; disorders associated with GK dysfunction; an enhanced solubility profile; improved metabolic stability; increased insulin secretion |
| 05/25/2006 | US20060111349 such as 3-[(Quinolin-4-ylmethyl)amino]-N-[4-methyl-3-(2-(4-(2-propyl)piperazin-1-yl)-3,4-dioxocyclobut-1-en-1-yl)phenyl]thiophene-2-carboxamide, having stem cell factor receptor inhibitory activity, used antitumor or anticarcinogenic agents |
| 05/25/2006 | US20060111303 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases |
| 05/24/2006 | EP1659120A1 3-substituted quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
| 05/24/2006 | EP1658285A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 05/24/2006 | EP1658273A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 05/24/2006 | EP1549639B1 Sulphonamide derivatives as antipsychotic agents |
| 05/24/2006 | EP1506185B1 Compounds and their use as inhibitors of 5-ht |
| 05/24/2006 | EP1355900B1 Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands |
| 05/24/2006 | EP1254904B1 Novel piperidine compounds and drugs containing the same |
| 05/24/2006 | DE102004055998A1 Niedermolekulare Inhibitoren von Guaninnucleotid-Austauschfaktoren der Cytohesin-Familie Small-molecule inhibitors of guanine nucleotide exchange factors of the cytohesin family |
| 05/24/2006 | DE102004055582A1 N-Heterocyclyl-phthalsäurediamide N-heterocyclyl-Phthalamides |
| 05/24/2006 | CN1777601A Nk-2 antagonist basic linear compounds and formulations containing them |
| 05/24/2006 | CN1777596A Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders |
| 05/24/2006 | CN1777584A (piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-ht 1f agonists |
| 05/24/2006 | CN1777582A Substituted indoline and indole derivatives |
| 05/24/2006 | CN1777427A Aminoheteroaryl compounds as protein kinase inhibitors |
| 05/24/2006 | CN1775778A Dithiophene ethene functional material, and its preparing method and use |
| 05/24/2006 | CN1775759A Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 05/24/2006 | CN1257160C Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 05/23/2006 | US7049444 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 05/23/2006 | US7049333 Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
| 05/23/2006 | US7049313 Induce immunology response; anticancer agents |
| 05/23/2006 | US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. |
| 05/23/2006 | US7048876 Photochromic compound exhibits absorption bands in two wavelength regions of 440 to 500 nm and 570 to 630 nm. |
| 05/23/2006 | CA2257200C Substituted imidazoles having cytokine inhibitory activity |
| 05/23/2006 | CA2158454C Taxanes having furyl or thienyl substituted side-chain |
| 05/18/2006 | WO2006053112A1 Process for preparing trisubstituted pyrimidine compounds |